切换至 "中华医学电子期刊资源库"

中华损伤与修复杂志(电子版) ›› 2017, Vol. 12 ›› Issue (02) : 138 -142. doi: 10.3877/cma.j.issn.1673-9450.2017.02.014

所属专题: 文献

综述

干细胞预处理及其保护机制的研究进展
黄宏1, 邱伟1, 陈民佳1, 张娅1, 安天琛1, 朱明1, 朱方强2,()   
  1. 1. 400042 重庆,第三军医大学大坪医院野战外科研究所,创伤、烧伤与复合伤国家重点实验室
    2. 401120 重庆医科大学第三附属医院泌尿外科
  • 收稿日期:2017-02-01 出版日期:2017-04-01
  • 通信作者: 朱方强
  • 基金资助:
    国家自然科学基金基金(81372059,81571912); 国家重点基础研究发展规划项目(2012CB518104,2012GB518105); 重庆高校创新团队建设计划资助项目(CXTDX201601005)

Preconditioning of mesenchymal stromal cells and its protection mechanism

Hong Huang1, Wei Qiu1, Minjia Chen1, Ya Zhang1, Tianchen An1, Ming Zhu1, Fangqiang Zhu2,()   

  1. 1. State Key Laboratory of Trauma, Burn and Combined Injury, Institute of Surgery Research, Daping Hospital, the Third Military Medical University, Chongqing 400042, China
    2. Department of Urinary Surgery, the Third Affiliated Hospital of Chongqing Medical University, Chongqing 401120, China
  • Received:2017-02-01 Published:2017-04-01
  • Corresponding author: Fangqiang Zhu
  • About author:
    Corresponding author: Zhu Fangqiang, Email:
引用本文:

黄宏, 邱伟, 陈民佳, 张娅, 安天琛, 朱明, 朱方强. 干细胞预处理及其保护机制的研究进展[J]. 中华损伤与修复杂志(电子版), 2017, 12(02): 138-142.

Hong Huang, Wei Qiu, Minjia Chen, Ya Zhang, Tianchen An, Ming Zhu, Fangqiang Zhu. Preconditioning of mesenchymal stromal cells and its protection mechanism[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2017, 12(02): 138-142.

干细胞移植治疗为临床疾病治疗开辟了新的天地,极具前景和希望,并取得了不错进展,然而,目前这一技术的应用却面临两大瓶颈问题:移植干细胞靶向性差和到达损伤部位存活率低下,严重阻碍了这一技术在临床广泛应用。而干细胞预处理为解决这两大难题带来了新希望,研究证实通过预处理干细胞可以明显改善其迁移、归巢和存活能力,为此,本文将对其相关研究作一综述。

Stem cell transplantation has opened up new worlds, with great prospects and hopes for clinical disease treatment, and it has made great progress. However, Bone mesenchyme stem cell therapy has been hindered by both key problems, lack of targetting/poor cell engraftment and apoptosis of the implanted cells, resulting in poor therapeutic effects thereby hampering extensive application of this technology in clinical. The stem cell pre-conditioning has brought new hope to solve these two problems. It has been proved that pretreatment of stem cells can improve its migration, homing and survival ability. To this end, the authours will review the related research.

1
Guenou H, Nissan X, Larcher F, et al. Human embryonic stem-cell derivatives for full reconstruction of the pluristratified epidermis: a preclinical study[J]. Lancet, 2009, 374(9703):1745-1753.
2
Dabiri G, Heiner D, Falanga V. The emerging use of bone marrow-derived mesenchymal stem cells in the treatment of human chronic wounds[J]. Expert Opin Emerg Drugs, 2013, 18(4):405-419
3
Amiri F, Jahanian-Najafabadi A, Roudkenar MH. In vitro augmentation of mesenchymal stem cells viability in stressful microenvironments[J]. Cell Stress Chaperones, 2015, 20(2):237-251.
4
Yu SP, Wei Z, Wei L. Preconditioning strategy in stem cell transplantation therapy[J]. Transl Stroke Res, 2013, 4(1):76-88.
5
Mastri M, Lin H, Lee T. Enhancing the efficacy of mesenchymal stem cell therapy[J]. World J Stem Cells, 2014, 6(2):82-93.
6
Robey TE, Saiget MK, Reinecke H, et al. Systems approaches to preventing transplanted cell death in cardiac repair[J]. J Mol Cell Cardiol, 2008, 45(4):567-581.
7
Cencioni C, Capogrossi MC, Napolitano M. The SDF-1/CXCR4 axis in stem cell preconditioning[J]. Cardiovasc Res, 2012, 94(3):400-407.
8
Lee S, Choi E, Cha MJ, et al. Cell adhesion and long-Term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapy[J]. Oxid Med Cell Longev, 2015, 2015:632902.
9
Haider HK, Ashraf M. Preconditioning and stem cell survival[J]. J Cardiovasc Transl Res, 2010, 3(2):89-102.
10
Yamaoka M, Yamaguchi S, Suzuki T, et al. Apoptosis in rat cardiac myocytes induced by Fas ligand: priming for Fas-mediated apoptosis with doxorubicin[J]. J Mol Cell Cardiol, 2000, 32(6):881-889.
11
Watanabe S, Arimura Y, Nagaishi K, et al. Conditioned mesenchymal stem cells produce pleiotropic gut trophic factors[J]. J Gastroenterol, 2014, 49(2):270-282.
12
Cai H, Zhang Z, Yang GY. Preconditioned stem cells: a promising strategy for cell-based ischemic stroke therapy[J]. Curr Drug Targets, 2014, 15(8):771-779.
13
Kim SW, Kim HW, Huang W, et al. Cardiac stem cells with electrical stimulation improve ischaemic heart function through regulation of connective tissue growth factor and miR-378[J]. Cardiovascular Res, 2013, 100(Suppl 2):241-251.
14
Yu HM, Zhi JL, Cui Y, et al. Role of the JAK-STAT pathway in protection of hydrogen peroxide preconditioning groat apoptosis induced by oxidative stress in PC12 cells[J]. Apoptosis, 2006, 11(6):931-941.
15
Mirotsou M, Zhang Z, Deb A, et al. Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair[J]. Proc Natl Acad Sci, 2007, 104(5):1643-1648.
16
Wang X, Zhang T, Huang W, et al. Hsp20-engineered mesenchymal stem cells are resistant to oxidative stress via enhanced activation of Akt and increased secretion of growth factors[J]. Stem Cells, 2009, 27(12):3021-3031.
17
Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway[J]. Annu Rev Pharmacol Toxicol, 2007, 47:89-116.
18
Mohammadzadeh M, Halabian R, Gharehbaghian A, et al. Nrf-2 overexpression in mesenchymal stem cells reduces oxidative stress-induced apoptosis and cytotoxicity[J]. Cell Stress Chaperones, 2012, 17(5):553-565.
19
Hamedi-Asl P, Halabian R, Bahmani P, et al. Adenovirus-mediated expression of the HO-1 protein within MSCs decreased cytotoxicity and inhibited apoptosis induced by oxidative stresses[J]. Cell Stress Chaperones, 2012, 17(2):181-190.
20
Kiani AA, Abdi J, Halabian R, et al. Over expression of HIF-1α in human mesenchymal stem cells increases their supportive functions for hematopoietic stem cells in an experimental co-culture model[J]. Hematology, 2014, 19(2):85-98.
21
Yu SP, Wei Z, Wei L. Preconditioning strategy in stem cell transplantation therapy[J]. Transl Stroke Res, 2013, 4(1):76-88.
22
Kameritsch P, Pogoda K, Pohl U. Channel-independent influence of connexin 43 on cell migration[J]. Biochim Biophys Acta, 2012, 1818(2):1993-2001.
23
Jaderstad J, Brismar H, Herlenius E. Hypoxia preconditioning increases gap-junctional graft and host communication[J]. Neuroreport, 2010, 21(17):1126-1132.
24
Chen J, Crawford R, Chen C, et al. The key regulatory roles of the PI3K/Akt signaling pathway in the functionalities of mesenchymal stem cells and applications in tissue regeneration[J]. Tissue Eng Part B Rev, 2013, 19(6):516-528.
25
Mangi AA, Noiseux N, Kong D, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infracted hearts[J]. Nat Med, 2003, 9(9):1195-1201.
26
Li W, Ma N, Ong LL, et al. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function[J]. Stem Cells, 2007, 25(8):2118-2127.
27
Yin Q, Jin P, Liu X, et al. SDF-1alpha inhibits hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells through PI3K/Akt and ERK1/2 signaling pathways[J]. Mol Biol Rep, 2011, 38(1):9-16.
28
Liu X, Duan B, Cheng Z, et al. SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion[J]. Protein Cell, 2011, 2(10):845-854.
29
Jang MW, Yun SP, Park JH, et al. Cooperation of Epac1/Rap1/Akt and PKA in prostaglandin E(2)-induced proliferation of human umbilical cord blood derived mesenchymal stem cells: involvement of c-Myc and VEGF expression[J]. J Cell Physiol, 2012, 227(12):3756-3767.
30
Bocker W, Docheva D, Prall WC, et al. IKK-2 is required for TNF-alphainduced invasion and proliferation of human mesenchymal stem cells[J]. J Mol Med, 2008, 86(10):1183-1192.
31
Tamama K, Fan VH, Griffith LG, et al. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells[J]. Stem Cells, 2006, 24(3):686-695.
32
Chavakis E, Koyanagi M, Dimmeler S. Enhancing the outcome of cell therapy for cardiac repair:progress from bench to bedside and back[J]. Circulation, 2010, 121(2):325-335.
33
Ip CK, Cheung AN, Ngan HY, et al. p70 S6 kinase in the control of actin cytoskeleton dynamics and directed migration of ovarian cancer cells[J]. Oncogene, 2011, 30(21):2420-2432.
34
Jiang P, Enomoto A, Jijiwa M, et al. An actin-binding protein Girdin regulates the motility of breast cancer cells[J]. Cancer Res, 2008, 68(5):1310-1318.
35
Liu X, Duan B, Cheng Z, et al. SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion[J]. Protein Cell, 2011, 2(10):845-854.
36
Gnecchi M, He H, Noiseux N, et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement[J]. FASEB J, 2006, 20(6):661-669.
37
Granero-Molto F, Myers TJ, Weis JA, et al. Mesenchymal stem cells expressing insulin-like growth factor-I (MSCIGF) promote fracture healing and restore new bone formation in Irs1 knockout mice: analyses of MSCIGF autocrine and paracrine regenerative effects[J]. Stem Cells, 2011, 29(10):1537-1548.
38
Cai L, Johnstone BH, Cook TG, et al. Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization[J]. Stem Cells, 2007, 25(12):3234-3243.
39
Wen Q, Zhou L, Zhou C, et al. Change in hepatocyte growth factor concentration promote mesenchymal stem cell-mediated osteogenic regeneration[J]. J Cell Mol Med, 2011, 16(6):1260-1273.
40
Pasha Z, Wang Y, Sheikh R, et al. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium[J]. Cardiovasc Res, 2008, 77(1):134-142.
41
Saxena A, Fish JE, White MD, et al. Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction[J]. Circulation, 2008, 117(17):2224-2231.
42
Chen J, Crawford R, Chen C, et al. The key regulatory roles of the PI3K/Akt signaling pathway in the functionalities of mesenchymal stem cells and applications in tissue regeneration[J]. Tissue Eng Part B Rev, 2013, 19(6):516-528.
43
Wang CY, Mayo MW, Korneluk RG, et al. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation[J]. Science, 1998, 281(5383):1680-1683.
44
Crisostomo PR, Wang Y, Markel TA, et al. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNKdependent mechanism[J]. Am J Physiol Cell Physiol, 2008, 294(1):675-682.
[1] 谢迎东, 孙帼, 徐超丽, 杨斌, 孙晖, 戴云. 超声造影定量评价不同生存期移植肾血流灌注的临床价值[J]. 中华医学超声杂志(电子版), 2023, 20(07): 749-754.
[2] 罗旺林, 杨传军, 许国星, 俞建国, 孙伟东, 颜文娟, 冯志. 开放性楔形胫骨高位截骨术不同植入材料的Meta分析[J]. 中华关节外科杂志(电子版), 2023, 17(06): 818-826.
[3] 刘林峰, 王增涛, 王云鹏, 钟硕, 郝丽文, 仇申强, 陈超. 足底内侧皮瓣联合甲骨皮瓣在手指V度缺损再造中的临床应用[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 480-484.
[4] 陈永沛, 仲海燕, 陈勇, 王慜, 王倩, 邹鸣立, 袁斯明. 数字减影血管造影在腓动脉穿支皮瓣移植中的应用[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 507-510.
[5] 韩李念, 王君. 放射性皮肤损伤治疗的研究进展[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 533-537.
[6] 刘竹影, 周年苟, 李泳祺, 周丽斌. 空心环钻联合手术导板用于自体牙移植牙槽窝备洞[J]. 中华口腔医学研究杂志(电子版), 2023, 17(06): 418-423.
[7] 叶晓琳, 刘云飞, 庞明泉, 王海久, 任利, 侯立朝, 于文昊, 王志鑫, 樊海宁. 肝再生细胞来源及调控机制的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 96-99.
[8] 严庆, 刘颖, 邓斐文, 陈焕伟. 微血管侵犯对肝癌肝移植患者生存预后的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 624-629.
[9] 廖梅, 张红君, 金洁玚, 吕艳, 任杰. 床旁超声造影对肝移植术后早期肝动脉血栓的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 630-634.
[10] 李秉林, 吕少诚, 潘飞, 姜涛, 樊华, 寇建涛, 贺强, 郎韧. 供肝灌注液病原菌与肝移植术后早期感染的相关性分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 656-660.
[11] 吕垒, 冯啸, 何凯明, 曾凯宁, 杨卿, 吕海金, 易慧敏, 易述红, 杨扬, 傅斌生. 改良金氏评分在儿童肝豆状核变性急性肝衰竭肝移植手术时机评估中价值并文献复习[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 661-668.
[12] 何吉鑫, 杨燕妮, 王继伟, 李建国, 谢铭. 肠道菌群及肠道代谢产物参与慢性便秘发生机制的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 495-499.
[13] 郭晓磊, 李晓云, 孙嘉怿, 金乐, 郭亚娟, 史新立. 含生长因子骨移植材料的研究进展和监管现状[J]. 中华老年骨科与康复电子杂志, 2023, 09(06): 373-378.
[14] 李田, 徐洪, 刘和亮. 尘肺病的相关研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 900-905.
[15] 王丁然, 迟洪滨. 自身免疫甲状腺炎对子宫内膜异位症患者胚胎移植结局的影响[J]. 中华临床医师杂志(电子版), 2023, 17(06): 682-688.
阅读次数
全文


摘要